Prognostic Impact of Myocardial Longitudinal Strain in Asymptomatic Aortic Stenosis: a Meta-Analysis
NCT ID: NCT02608567
Last Updated: 2017-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2015-10-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Value of Myocardial Fibrosis in Severe Aortic Valve Stenosis
NCT03585933
Valvular Aortic Stenosis Prognosis Study
NCT03628313
MRI in Randomised Cohorts of Asymptomatic AS
NCT05178368
Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve
NCT02727504
Microvascular Dysfunction in Aortic Stenosis
NCT01658345
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preserved LV GLS
Patients will be compared according to the level of LV global longitudinal strain (GLS) as derived from transthoracic echocardiography and speckle tracking analysis.
Two groups will be compared regarding outcome: preserved LV GLS vs. reduced LV GLS. The definition use for reduced LV GLS will be \>-16%. An optimal threshold would also be calculated and derived from the pooled data.
No interventions assigned to this group
Reduced LV GLS
The definition use for reduced LV GLS will be \>-16%. An optimal threshold would also be calculated and derived from the pooled data.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Studies with cohort of patients with aortic valve replacement indication
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Association of Cardiovascular Imaging
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julien Magne
EACVI board member - Research&Innovation committee member
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erwan Donal, MD, PhD
Role: STUDY_CHAIR
European Association of Cardiovascular Imaging
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU LImoges
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EACVI-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.